Bristol-Myers Squibb (BMY) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Bristol-Myers (BMY) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 29, 2024 (05:51)

Sector: Healthcare

The share price of Bristol-Myers Squibb Comp. (BMY) now

Latest session on the 28th of March for
Bristol-Myers Squibb Comp. is positive
Trading Volume: 14348196
Open: 53.39 /  High: 54.475 /  Low: 53.39
What analysts predict: $51.82
52-week High/Low: $68.94 / $47.58

50/200 Day Moving Average: $50.68 / $55.76

This figure corresponds to the Average Price over the previous 50/200 days. For Bristol-Myers Squibb stocks, the 50-day moving average is the support level today.

For Bristol-Myers Squibb stocks, the 200-day moving average is the resistance level today.

Are you interested in Bristol-Myers Squibb Comp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bristol-Myers Squibb stock price in 2024, 2025, 2026, 2027, 2028. How much will one Bristol-Myers Squibb share be worth in 2024 - 2028?

When should I take profit in Bristol-Myers Squibb stock? When should I record a loss on Bristol-Myers Squibb stock? What are analysts' forecasts for Bristol-Myers Squibb stock? What is the future of Bristol-Myers Squibb stock? We forecast Bristol-Myers Squibb stock performance using neural networks based on historical data on Bristol-Myers Squibb stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Bristol-Myers Squibb stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Bristol-Myers Squibb shares. This happens once a day.


Historical and forecast chart of Bristol-Myers Squibb stock

The chart below shows the historical price of Bristol-Myers Squibb stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Bristol-Myers Squibb stock price can be found in the table below.

Long-term forecasts by years.

Bristol-Myers Squibb is an American pharmaceutical company. Develops drugs in various areas of medicine, including: oncology, HIV / acquired immunodeficiency syndrome, cardiovascular diseases, diabetes, hepatitis B and C, rheumatoid arthritis and mental disorders. The mission of the company is to discover, develop and supply innovative medicines to patients so that they can overcome serious illnesses. The mission also means that the company is working to ensure that patients have access to healthcare through public and private partners. The firm’s strategy combines the scale and resources of a large pharmaceutical corporation with the entrepreneurial spirit and agility of a successful biotech firm.

Bristol-Myers Squibb started out as two different companies – Bristol-Myers and Squibb. The Squibb Corporation was formed in 1858 in Brooklyn, New York. Founder Edward Robinson Squibb was a preeminent proponent of quality control and high purity standards within the emerging pharmaceutical industry of his day. After a failed attempt to convince the American Medical Association to accept higher frequency standards, he independently published an alternative to the US Pharmacopoeia (Squibb’s Ephemeris of Materia Medica). In 1887, Hamilton College alumni William McLaren Bristol and John Ripley Myers bought Clinton Pharmaceutical from Clinton, Oneida County, New York. After Myers’ death in 1899, Bristol changed its name to Bristol-Myers Corporation. The first nationally recognized product was Sal Hepatica, a laxative mineral salt in 1903. Its second national success was the Ipana toothpaste, from 1901 to 1960. The second national success was with Ipana toothpaste, from 1901 to 1960. Bristol-Myers and Squibb merged to form Bristol-Myers Squibb in 1989.

Official site of the company

Bristol-Myers Squibb daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 31 54.59 54.40 55.00 1.10
Apr 01 54.51 53.98 54.85 1.61
Apr 02 54.49 54.05 54.90 1.57
Apr 03 54.20 53.73 54.73 1.86
Apr 04 54.53 54.14 54.99 1.57
Apr 05 54.83 54.61 55.22 1.12
Apr 06 54.61 54.45 55.17 1.33
Apr 07 54.92 54.51 55.19 1.24
Apr 08 55.45 55.22 55.83 1.10
Apr 09 55.47 54.93 55.74 1.48
Apr 10 54.70 54.12 55.26 2.09
Apr 11 55.43 55.07 55.74 1.21
Apr 12 55.72 55.55 55.88 0.60
Apr 13 56.00 55.52 56.56 1.88
Apr 14 56.56 55.98 56.75 1.37
Apr 15 56.64 56.18 57.02 1.50
Apr 16 57.06 56.62 57.64 1.79
Apr 17 56.70 56.11 57.08 1.73
Apr 18 56.10 55.53 56.52 1.80
Apr 19 55.98 55.50 56.34 1.51
Apr 20 56.08 55.61 56.42 1.45
Apr 21 55.61 55.11 56.10 1.81
Apr 22 56.11 55.72 56.56 1.51
Apr 23 56.25 55.63 56.78 2.07
Apr 24 55.86 55.62 56.49 1.56
Apr 25 56.16 55.65 56.39 1.33
Apr 26 55.65 55.38 56.08 1.27
Apr 27 55.33 55.09 55.73 1.17
Apr 28 54.82 54.54 55.19 1.20
Apr 29 54.67 54.29 55.21 1.71

Bristol-Myers Squibb Daily Price Targets


Bristol-Myers Squibb Stock Forecast 03-31-2024.

Forecast target price for 03-31-2024: $54.59.
Positive dynamics for Bristol-Myers Squibb shares will prevail with possible volatility of 1.084%.
Pessimistic target level: 54.40
Optimistic target level: 55.00

Bristol-Myers Squibb Stock Forecast 04-01-2024.

Forecast target price for 04-01-2024: $54.51.
Negative dynamics for Bristol-Myers Squibb shares will prevail with possible volatility of 1.586%.
Pessimistic target level: 53.98
Optimistic target level: 54.85

Bristol-Myers Squibb Stock Forecast 04-02-2024.

Forecast target price for 04-02-2024: $54.49.
Negative dynamics for Bristol-Myers Squibb shares will prevail with possible volatility of 1.542%.
Pessimistic target level: 54.05
Optimistic target level: 54.90

Bristol-Myers Squibb Stock Forecast 04-03-2024.

Forecast target price for 04-03-2024: $54.20.
Negative dynamics for Bristol-Myers Squibb shares will prevail with possible volatility of 1.830%.
Pessimistic target level: 53.73
Optimistic target level: 54.73

Bristol-Myers Squibb Stock Forecast 04-04-2024.

Forecast target price for 04-04-2024: $54.53.
Positive dynamics for Bristol-Myers Squibb shares will prevail with possible volatility of 1.541%.
Pessimistic target level: 54.14
Optimistic target level: 54.99

Bristol-Myers Squibb Stock Forecast 04-05-2024.

Forecast target price for 04-05-2024: $54.83.
Positive dynamics for Bristol-Myers Squibb shares will prevail with possible volatility of 1.112%.
Pessimistic target level: 54.61
Optimistic target level: 55.22

BMY (BMY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 53.91 51.66 54.80 5.74
May. 53.73 52.64 54.53 3.47
Jun. 53.23 52.38 54.96 4.69
Jul. 50.77 50.10 51.86 3.39
Aug. 48.09 47.51 49.17 3.39
Sep. 47.06 46.49 48.01 3.18
Oct. 47.01 45.58 49.00 6.97
Nov. 46.28 45.42 47.50 4.39
Dec. 47.55 46.43 49.20 5.63

Bristol-Myers Squibb forecast for this year


Bristol-Myers Squibb Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $53.9084. Pessimistic: $51.66. Optimistic: $54.80


Bristol-Myers Squibb Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $53.7305. Pessimistic: $52.64. Optimistic: $54.53


Bristol-Myers Squibb Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $53.2281. Pessimistic: $52.38. Optimistic: $54.96


Bristol-Myers Squibb Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $50.769. Pessimistic: $50.10. Optimistic: $51.86


Bristol-Myers Squibb Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $48.0884. Pessimistic: $47.51. Optimistic: $49.17


Bristol-Myers Squibb Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $47.0569. Pessimistic: $46.49. Optimistic: $48.01


Bristol-Myers Squibb Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $47.0051. Pessimistic: $45.58. Optimistic: $49.00


Bristol-Myers Squibb Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $46.2813. Pessimistic: $45.42. Optimistic: $47.50


Bristol-Myers Squibb Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $47.554. Pessimistic: $46.43. Optimistic: $49.20



Bristol-Myers Squibb (BMY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 47.37 45.29 48.33 6.31
Feb 45.18 44.19 46.05 4.05
Mar 44.54 43.09 46.23 6.78
Apr 45.32 44.10 46.42 4.99
May 45.32 43.95 46.54 5.57
Jun 44.72 42.98 46.25 7.07
Jul 46.76 46.09 47.36 2.66
Aug 47.51 45.86 48.84 6.10
Sep 47.80 46.69 49.06 4.82
Oct 47.48 46.31 48.94 5.39
Nov 47.61 46.09 49.29 6.48
Dec 48.08 46.52 49.78 6.53

Bristol-Myers Squibb (BMY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 48.24 46.23 50.36 8.22
Feb 48.30 47.21 49.68 4.97
Mar 48.75 47.62 49.98 4.72
Apr 49.93 49.21 51.79 4.98
May 50.17 48.32 51.50 6.16
Jun 52.93 52.29 55.03 4.97
Jul 52.73 50.79 53.34 4.78
Aug 50.00 48.46 50.66 4.34
Sep 51.32 50.50 53.44 5.49
Oct 51.46 50.90 52.54 3.12
Nov 52.62 51.76 54.65 5.30
Dec 52.57 50.69 53.72 5.65

Bristol-Myers Squibb (BMY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 51.90 49.76 52.79 5.73
Feb 52.73 50.53 55.05 8.22
Mar 52.85 51.22 53.43 4.13
Apr 52.47 50.97 53.97 5.56
May 52.99 51.76 54.30 4.67
Jun 54.04 52.79 55.14 4.26
Jul 51.69 49.67 52.51 5.41
Aug 48.87 47.85 49.73 3.78
Sep 47.80 46.04 49.03 6.11
Oct 48.14 46.63 49.86 6.48
Nov 47.45 46.70 48.05 2.82
Dec 46.85 46.16 48.66 5.14

Bristol-Myers Squibb (BMY) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 47.32 46.04 49.22 6.45
Feb 49.84 49.07 51.57 4.84
Mar 49.26 48.10 51.24 6.13
Apr 49.21 47.56 49.97 4.82
May 48.07 47.54 49.92 4.77
Jun 47.44 45.95 48.35 4.96
Jul 46.84 45.14 47.66 5.30
Aug 46.99 45.78 49.06 6.69
Sep 46.27 45.56 47.90 4.89
Oct 43.75 43.00 44.50 3.35
Nov 42.72 41.19 43.35 4.99
Dec 43.80 42.52 44.49 4.44

Bristol-Myers Squibb information and performance

Bristol-Myers Squibb Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization: 106 266 083 000 $

Market capitalization of the Bristol-Myers Squibb Comp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BMY shares in the company outstanding by the market price of one share.

EBITDA: 18 420 001 000 $

EBITDA of Bristol-Myers Squibb is earnings before interest, income tax and depreciation of assets.

PE Ratio: 13.54

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.371

Price/earnings to growth

DPS: 2.31

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0459

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.88

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.089
Quarterly Revenue Growth YOY: 0.006
Trailing PE: 13.54

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 7.35

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.996

Enterprise Value (EV) /Revenue

EV To EBITDA: 6.96

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2022190000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Bristol-Myers Squibb (BMY) stock dividend

Bristol-Myers Squibb last paid dividends on 04/04/2024. The next scheduled payment will be on 05/01/2024. The amount of dividends is $2.31 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.